Biopharma News : Biopharma and Pharma news from all around the world :
- Opdivo® (nivolumab) Plus Yervoy® (ipilimumab) Demonstrates Durable Survival Benefit vs. Chemotherapy in Patients with Previously Untreated Malignant Pleural Mesothelioma
- ADDING MULTIMEDIA FDA Approves Genentech’s Evrysdi (risdiplam) for Treatment of Spinal Muscular Atrophy (SMA) in Adults and Children 2 Months and Older
- FSD Pharma Reports Second Quarter 2020 Financial Results
- Insights on the Global Osteoarthritis Therapeutics Market 2020-2024 |COVID-19 Analysis, Drivers, Restraints, Opportunities and Threats | Technavio
- Bophelo Enters into $30 Million Offtake Agreement with Medcan
- Veracyte Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
- Outlook on the Worldwide Hunter Syndrome Industry to 2030 – ResearchAndMarkets.com
- Global Aspergillosis Market to 2030 – Insights, Epidemiology and Market Forecast – ResearchAndMarkets.com
- Mirum Pharmaceuticals to Present at the Canaccord Genuity 40th Annual Growth Conference
- FDA Approves Genentech’s Evrysdi (risdiplam) for Treatment of Spinal Muscular Atrophy (SMA) in Adults and Children 2 Months and Older
- 2020 Beta Secretase Inhibitor Pipeline Insight – ResearchAndMarkets.com
- Worldwide Potassium Citrate Industry to 2027 – Impact of COVID-19 on the Market – ResearchAndMarkets.com
- Laboratory Information Systems Market 2020-2030: COVID-19 Impact – ResearchAndMarkets.com
- Schwazze, Formerly Operating as Medicine Man Technologies, Inc., to Host Second Quarter 2020 Conference Call and Webcast on August 13, 2020
- Global Otamixaban (CAS 193153-04-7) Market Research Report 2020 – ResearchAndMarkets.com
- Transcatheter Mitral Valve Replacement Company InnovHeart Closes Series B Financing of €20 Million
- Global Bioremediation Technology & Services Market Outlook (2019 to 2027) – Featuring Ivey International, Probiosphere & Regenes Among Others – ResearchAndMarkets.com
- NIH grants $1.44M to Cancer Targeted Technology to Support the Ongoing Prostate Cancer Clinical Trial of a Promising New Radiotherapeutic, CTT1403
- Illumina to Webcast Upcoming Investor Conference Presentation
- Cerus INTERCEPT Blood System Kit Shipments Surpass 7.5 Million Treatable Platelet and Plasma Doses Since Launch
- COVID-19 Impacts: Fermentation Chemicals Market Will Accelerate at a CAGR of About 6% Through 2020-2024 | Increased Usage of Organic Acids in Cosmetics and Personal Care Products to Boost Growth | Technavio
- CStone Announces That OmniAb-derived CS1001 (Anti-PD-L1) Phase 3 Trial Met the Primary Endpoint as First-Line Treatment in Stage IV Squamous and Non-squamous Non-Small Cell Lung Cancer and Announces Plans to Submit a New Drug Application
- Merrimack Reports Second Quarter 2020 Financial Results
- Aimmune Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
- Bruker Announces Quarterly Dividend
- Pfizer Announces Agreement with Gilead to Manufacture Remdesivir for Treatment of COVID-19
- Senseonics Announces Positive Coverage Decision for Eversense CGM from Highmark Inc.
- U.S. Food and Drug Administration Approves Lampit® (nifurtimox) for the Treatment of Chagas Disease in Children
- Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan
- Avacta Announces SARS-CoV-2 Rapid Antigen Test Clinical Collaboration
Biotech – Biopharma News!
- PAION ANNOUNCES SUCCESSFUL PRODUCT LAUNCH OF ANEREM (REMIMAZOLAM) IN JAPAN BY MUNDIPHARMA
- Release of results for the third quarter 2019/20 (ending 30 June 2020) on 13 August 2020
- RHÖN-KLINIKUM AG concludes the first six months of 2020 with increased revenues – Huge contribution towards fighting COVID-19 pandemic – Strategic partnership with Asklepios
- MorphoSys Reports Second Quarter and First Half 2020 Results
- aap Implantate AG offers its shareholders a convertible bond with a total nominal value of EUR 2.6 million; attractive offer and a major step toward securing the company’s continued existence
- Xlife Sciences AG: Xlife Sciences takes stake in palleos healthcare
- EVOTEC SE TO REPORT FIRST HALF-YEAR 2020 RESULTS ON 12 AUGUST 2020
- Medios AG: Dynamic sales growth in the first half of 2020, special effects burden earnings
- Medios AG adjusts forecast for 2020 financial year downward
- EVOTEC AND SECARNA PHARMACEUTICALS FORM STRATEGIC PARTNERSHIP IN THE FIELD OF ANTISENSE THERAPY
- Secarna Pharmaceuticals and Evotec form strategic partnership in the field of antisense therapy
- Vivoryon Therapeutics AG: Vivoryon Receives IND Approval for Varoglutamstat’s (PQ912) Phase 2 Study in Alzheimer’s Disease
- PAION ANNOUNCES APPROVAL OF COMPASSIONATE USE PROGRAM FOR REMIMAZOLAM IN BELGIUM
- Sales Q2/2020 and H1/2020: Continued dynamic development in the U.S. with double-digit growth rates; international and German business strongly impacted by COVID-19 pandemic
- Polyphor announces second positive Data Safety Monitoring Board recommendation to continue Phase III FORTRESS study without modifications
- Siemens Healthineers plans acquisition of Varian
- FDA Approves Monjuvi(R) (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
- MorphoSys AG: Ad hoc: FDA Approves Monjuvi(R) (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
- Zur Rose Group successfully concluded acquisition of TeleClinic
- Corona-related precautious free capacities reserved as a precaution in the second quarter of 2020 led to a decline in sales and earnings in the Group – a reliable forecast for the 2020 financial year is not yet possible
- Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2020 (IFRS)
- Invitation to MorphoSys’ Second Quarter and First Half 2020 Results Conference Call on August 6, 2020
- Eckert & Ziegler: Implementation of the share split by issuing bonus shares to be effective on 4 August 2020
- Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care delivers very strong second quarter results
- Apogenix to Start European Clinical Phase II Trial with Asunercept in COVID-19 Patients
- 4basebio AG: 4basebio informs about takeover bid by Sparta AG
- Polyphor strengthens financial flexibility with CHF 19.3 million equity-linked financing
- Eckert & Ziegler Increases Profit Forecast to 4 Euro per Share
- Xlife Sciences AG: New project company x-nuclear diagnostic GmbH acquires new proprietary technology in nuclear medical diagnostics
- Heidelberg Pharma AG: Annual General Meeting 2020 of Heidelberg Pharma Approves All Proposed Resolutions
- Aino Health AB (publ): Aino Health decides on a fully secured rights issue of shares of approximately SEK 15.9 million
- Lung cancer researchers present new clinical trial data at International Association for the Study of Lung Cancer World Conference on Lung Cancer Virtual Presidential Symposium
- SeaSpine Reports Granting of Inducement Awards
- MannKind Corporation to Participate in BTIG Virtual Biotechnology Conference 2020
- Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Eidos Therapeutics Appoints Industry Leaders With Significant Development and Commercial Expertise to Board of Directors
- Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- TOMI Environmental Solutions, Inc. to Hold Second Quarter 2020 Financial Results Conference Call on Thursday, August 13, 2020
- Amarin Supports Investigator-Initiated Trial at Kaiser Permanente in the U.S. to Study the Effects of VASCEPA® (icosapent ethyl) in Reducing Viral Upper Respiratory Infections, Including COVID-19 and Flu, and the Clinical Severity of Such Infections
- Valneva – Déclaration d’actions et de droits de vote – JUILLET 2020
- Arch Biopartners to Hold LSALT Peptide Webinar and Q&A Session August 18, 2020 at 11am EST
- RedHill Biopharma to Host Second Quarter Financial Results and Business Highlights Conference Call and Webcast on August 13, 2020
- Lord Global Corp., soon to be 27Health Holdings Corp. (OTC:LRDG), and venture partner J.A. Lafayette have signed a financing and marketing agreement with Innovative Regulatory Risk Advisors LLC
- Precipio Announces Q2-2020 Corporate Update Call For Shareholders
- Todos Medical Announces July Sales of COVID-19 Tests
- Golden Leaf Holdings to Report Second Quarter Earnings
- Resonant to Present at Oppenheimer 23rd Annual Virtual Technology, Internet & Communications Conference on August 11th
- Pacific Biosciences Announces New Chief Executive Officer
- BBS-Bioactive Bone Substitutes Plc: The CE marking application of the Company’s ARTEBONEⓇ Paste product is in progress
- Freeline Announces Pricing of Initial Public Offering
- ASLAN Pharmaceuticals to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference 2020
- Dr James Khodabakhsh MD named Chairman of the Scientific Advisory Board at OKYO Pharma Ltd
- Acarix AB (publ) publishes Interim Report, January – June 2020
- ObsEva SA to present at the Wedbush PacGrow Healthcare Virtual Conference, August 11 – 12, 2020
- MDxHealth Provides Update on Medicare Coverage for SelectMDx
- ARYA Sciences Acquisition Corp III Announces Pricing of $130 Million Initial Public Offering
- Checkmate Pharmaceuticals Announces Pricing of Initial Public Offering
- Osmotica Pharmaceuticals plc to Provide Second Quarter 2020 Business and Financial Update and Presentation on Upneeq™ on August 11, 2020
- Nova Leap Health Corp. Posts Financial Results for Second Quarter 2020
- MediPharm Labs Announces Release of $18.9 Million in Escrowed Funds
.
Biotech – Biopharma News!
Every day, Biotech 365 brings you information about Biotech Companies, Biopharma News, Biotech Tools, Bioinformatic tips and BioMarketplace ! To receive weekly notifications about Biopharma News and the last articles added to Biotech 365, please register to our Newsletter. And please Follow Biotech 365 on Twitter ( https://twitter.com/Biotech365 ) and LinkedIn (www.linkedin.com/company/biotech-365 ) … thanks !!!
Biotech 365 is an independent website, sharing information and news about Biotech Companies, Biotechnology, Biopharma News and Pharma News. If you want to contribute, you’re welcome! Please do not hesitate to Contact us ! Thanks !!!
Lots of very interesting and promising Biopharma Companies emerge everyday around the world. Looking for new partners? For new suppliers or clients? Biotech-365.com will present you lots of Biotech companies from all around the world and keep you informed about the last Biopharma news ! Don’t lose your time searching for new Biotech or Biopharma partners! The most interesting ones are on Biotech-365.com !
You want to propose a Biotech Company, a Biotech Tool or a Bioinformatic software to be presented on Biotech-365.com? Please use our Contact page ! Interested in becoming our partner? Please Contact us ! Thanks !!! If you want to promote your Biotech company or Biopharma Company on our website, please check our Offers! Biotech 365 brings you every day the more interesting information about Biopharma News, Biotech Companies and Biotech Tools! Enjoy them with a good coffee and share with your teammates!
Biopharma News – Pharma News
Biotech 365 : daily news about Biotech and Biopharma
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites ! Thanks !
Biopharma News – Pharma News
Biopharma News – Pharma News